Brooklyn ImmunoTherapeutics Insider Trades

BTX

Track insider trading activity from Brooklyn ImmunoTherapeutics executives and directors. See which insiders are buying and selling BTX stock.

Trades Last 12 Months

All Insider Trades for Brooklyn ImmunoTherapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Menge Steven Reid other, Portfolio Manager
Holding Value $38.2k 4,136 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.6k 4,136 shares
$6.68
$9.24
Kim Tony other, Portfolio Manager
Holding Value $270k 29,270 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$196k 29,270 shares
$6.68
$9.24
Holding Value $0 0 shares
Last Trade
Dec 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$0 0 shares
$6.55
$9.24
Holding Value $0 0 shares
Last Trade
Jul 09, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$454M 60,675,395 shares
$7.49
$9.24
Luther Sanjeev President And CEO
Holding Value $15.6M 1,685,218 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 1,685,218 shares
$0.21
$9.24
Clarke Dorothy J General Counsel
Holding Value $1.56M 168,521 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.6k 168,521 shares
$0.21
$9.24
Holding Value $18.4M 1,991,394 shares
Last Trade
Dec 15, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$321k 1,562,988 shares
$0.21
$9.24
Cherington Charles 10% owner
Holding Value $28.9M 3,125,976 shares
Last Trade
Dec 14, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.22M 5,957,180 shares
$0.21
$9.24
Gurrola Sandra M Vice President Of Finance
Holding Value $8.57k 928 shares
Last Trade
Jun 21, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$36.7 179 shares
$0.21
$9.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up